FDA Approves Vertex’s JOURNAVX as First Non-Opioid Acute Pain Reliever - Inside Precision Medicine
Vertex's JOURNAVX (suzetrigine) underscores the shift toward safer, more effective pain management strategies.
Search Group
Share To
Comments
About Screade
Screade® Inc. version f7eb701, copyright 2016 - 2025
Blocked Users
Customize Dark Theme
Forgot your password?
Forgot your password?
Invite your friends
Please type emails of people you want to invite, we will send them invitation email on your behalf. Separate emails with comma if you want to invite multiple friends.
Comments